Cargando…

High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma

BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is malignancies of the biliary duct system and constitutes approximately 10%-20% of all primary liver cancers. Tumor mutation burden (TMB) is a useful biomarker across many cancer types for the identification of patients who will benefit from immunot...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jian-Ping, Liu, Xue-Zhi, Chen, Qian, Liu, Yan-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790456/
https://www.ncbi.nlm.nih.gov/pubmed/35127895
http://dx.doi.org/10.12998/wjcc.v10.i3.790
_version_ 1784640013088063488
author Song, Jian-Ping
Liu, Xue-Zhi
Chen, Qian
Liu, Yan-Feng
author_facet Song, Jian-Ping
Liu, Xue-Zhi
Chen, Qian
Liu, Yan-Feng
author_sort Song, Jian-Ping
collection PubMed
description BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is malignancies of the biliary duct system and constitutes approximately 10%-20% of all primary liver cancers. Tumor mutation burden (TMB) is a useful biomarker across many cancer types for the identification of patients who will benefit from immunotherapy. Despite the role of TMB in calculating the effectiveness and prognosis of immune checkpoint inhibitors has been confirmed in multiple human cancer types, the prognostic value of TMB in ICC patients is rare investigated. AIM: To investigate the prognostic value of TMB in patients with ICC. METHODS: Data of 412 patients with ICC were included in the study. TMB was calculated as the total number of somatic non-silent protein-coding mutations divided by the coding region. The Kaplan-Meier method was used to analyze overall survival (OS), and relapse free survival (RFS). The cut-off value of TMB was determined by time-dependent receiver operating characteristic (ROC) curve. Cox regression was performed for multivariable analysis of OS. The nomogram and calibration curve were analyzed to construct and evaluate the prognostic model. RESULTS: In the analysis of the time-dependent ROC curve, we defined 3.1 mut/Mb as the cut-off value of TMB. The Kaplan-Meier plot revealed that patients with high TMB had poor OS (HR = 1.47, P = 0.002) and RFS (HR = 1.42, P = 0.035). Cox regression analysis also demonstrated that TMB was an independent risk predictor for ICC (HR = 1.43, P = 0.0240). Furthermore, independent prognostic factors of ICC included CA19-9 (HR = 1.78, P = 0.0005), chronic viral hepatitis (HR = 1.72, P = 0.0468), tumor resection (HR = 2.58, P < 0.0001) and disease progression (metastatic disease vs. solitary liver tumor; HR = 2.55, P = 0.0002). The nomogram and calibration curve also indicated the effectiveness of the constructed prognostic model. CONCLUSION: TMB was an independent prognostic biomarker in patients with ICC. Moreover, patients with ICC with high TMB had poor OS and RFS as compared to those with low TMB.
format Online
Article
Text
id pubmed-8790456
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-87904562022-02-03 High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma Song, Jian-Ping Liu, Xue-Zhi Chen, Qian Liu, Yan-Feng World J Clin Cases Retrospective Cohort Study BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is malignancies of the biliary duct system and constitutes approximately 10%-20% of all primary liver cancers. Tumor mutation burden (TMB) is a useful biomarker across many cancer types for the identification of patients who will benefit from immunotherapy. Despite the role of TMB in calculating the effectiveness and prognosis of immune checkpoint inhibitors has been confirmed in multiple human cancer types, the prognostic value of TMB in ICC patients is rare investigated. AIM: To investigate the prognostic value of TMB in patients with ICC. METHODS: Data of 412 patients with ICC were included in the study. TMB was calculated as the total number of somatic non-silent protein-coding mutations divided by the coding region. The Kaplan-Meier method was used to analyze overall survival (OS), and relapse free survival (RFS). The cut-off value of TMB was determined by time-dependent receiver operating characteristic (ROC) curve. Cox regression was performed for multivariable analysis of OS. The nomogram and calibration curve were analyzed to construct and evaluate the prognostic model. RESULTS: In the analysis of the time-dependent ROC curve, we defined 3.1 mut/Mb as the cut-off value of TMB. The Kaplan-Meier plot revealed that patients with high TMB had poor OS (HR = 1.47, P = 0.002) and RFS (HR = 1.42, P = 0.035). Cox regression analysis also demonstrated that TMB was an independent risk predictor for ICC (HR = 1.43, P = 0.0240). Furthermore, independent prognostic factors of ICC included CA19-9 (HR = 1.78, P = 0.0005), chronic viral hepatitis (HR = 1.72, P = 0.0468), tumor resection (HR = 2.58, P < 0.0001) and disease progression (metastatic disease vs. solitary liver tumor; HR = 2.55, P = 0.0002). The nomogram and calibration curve also indicated the effectiveness of the constructed prognostic model. CONCLUSION: TMB was an independent prognostic biomarker in patients with ICC. Moreover, patients with ICC with high TMB had poor OS and RFS as compared to those with low TMB. Baishideng Publishing Group Inc 2022-01-21 2022-01-21 /pmc/articles/PMC8790456/ /pubmed/35127895 http://dx.doi.org/10.12998/wjcc.v10.i3.790 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Retrospective Cohort Study
Song, Jian-Ping
Liu, Xue-Zhi
Chen, Qian
Liu, Yan-Feng
High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
title High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
title_full High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
title_fullStr High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
title_full_unstemmed High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
title_short High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
title_sort high tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
topic Retrospective Cohort Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790456/
https://www.ncbi.nlm.nih.gov/pubmed/35127895
http://dx.doi.org/10.12998/wjcc.v10.i3.790
work_keys_str_mv AT songjianping hightumormutationburdenindicatesapoorprognosisinpatientswithintrahepaticcholangiocarcinoma
AT liuxuezhi hightumormutationburdenindicatesapoorprognosisinpatientswithintrahepaticcholangiocarcinoma
AT chenqian hightumormutationburdenindicatesapoorprognosisinpatientswithintrahepaticcholangiocarcinoma
AT liuyanfeng hightumormutationburdenindicatesapoorprognosisinpatientswithintrahepaticcholangiocarcinoma